February 2016

Statin use does not reduce risk of acute kidney injury following cardiac surgery ()
Abbott initiates voluntary MitraClip delivery system safety notice ()
AHA enacts tougher anti-smoking policy for cities hosting its conferences ()
Women have lower one-year mortality rates after TAVR with the Sapien valve ()
Most FDA-approved high-risk cardiovascular device studies are published in peer-reviewed literature ()
As FDA commissioner, Califf plans on focusing on evidence-based medicine ()
ACC releases lifelong learning competencies document for cardiologists ()
Physicians preach caution when interpreting and implementing SPRINT trial results ()
Boston Scientific chairman and co-founder to retire in May; CEO will replace him ()
Senate confirms Califf as FDA commissioner ()
FDA approves Boston Scientific’s quadripolar leads ()
Death rates associated with in-hospital cardiogenic shock following acute MI decline in recent years ()
FDA rejects expanded indications for Merck cholesterol drugs ()
High-dose tirofiban during PCI is associated with significant reduction in all-cause mortality ()
Stenting and endarterectomy have similar outcomes in asymptomatic patients with severe carotid stenosis ()
After stroke, Pioglitazone reduces risk of MI or subsequent stroke ()
Neurological improvement following strokes may still lead to unfavorable outcomes ()
Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial ()
Medtronic Receives CE Mark for Full Line of Cardiac Resynchronization Therapy-Defibrillators Compatible with MRI Scans ()
Untreated hypertension leads to increased risk of intracerebral hemorrhage ()
Hospital reimbursement for alteplase does not match up with increased costs ()
DOJ reaches settlements with 51 hospitals for allegedly improperly implanting ICDs ()
Therox Enrolls First Patient in Study of Next-Generation Supersaturated Oxygen Therapy for Ami ()
Medtronic increases cash dividend 25 percent for fiscal year’s fourth quarter ()
FDA approves St. Jude Medical’s pacing technology, leads and quartet test ()
Mended Hearts launches LVAD video contest ()
Stryker agrees to acquire Physio-Control for $1.28 billion ()
ACC, AHA express concern with conflicting blood pressure measure sets ()
Stroke researchers and scientists receive national awards ()
International stroke conference features more than 1,500 presentations ()
Nearly 17 million U.S. adults may benefit from lowering systolic blood pressure goal ()
Paris Cardiology Center Improves Cath Lab Offering with Toshiba’s Cardiovascular X-ray ()
Senate plans on holding a procedural vote on Califf’s nomination for FDA commissioner ()
Model finds the CardioMEMS device is cost-effective for heart failure patients ()
Harvard researchers examine PCI readmission metric ()
Cook Medical voluntarily recalls catheters, pressure monitoring sets and trays ()
Software Leaders Collaborate to Develop Powerful Cardiovascular EHR System ()
[VIDEO] Building a Protected PCI Program: The Community Hospital Approach ()
IBHRE Promotes Certification among Heart Rhythm Examiners ()
CMS decision may expand use of Watchman device in the U.S. ()
Contrary to popular perception, inpatient echo may not be used enough ()
ACC announces late-breaking clinical trials for annual scientific session ()
Hospital ratings at a glance ()
Novartis agrees to pay-for-performance agreements with insurers to cover heart failure drug ()
CMS releases national coverage determination for Watchman and other LAA devices ()
New Real-World Comparison Showing Similar Efficacy Between the Lutonix® and In.Pact™ Drug-Coated Balloons Featured at LINC 2016 ()
TAVR procedure saves Selma’s first black police chief ()
Abiomed’s quarterly revenue increases 38% ()
Prices of pacemakers, defibrillators and other devices are declining ()
FDA grants Spectranetics bridge occlusion balloon 510(k) clearance ()
Spectranetics Receives FDA 510(k) Clearance for Bridge™ Occlusion Balloon for Lead Extraction Procedures ()
FDA approves Medtronic's MRI conditional CRT defibrillators for heart failure patients ()
Edwards Lifesciences agrees to repurchase $325 million of its common stock ()
Boston Scientific’s revenue and earnings per share increase in Q4 ()
Merit Medical acquires vascular access system for $18.5 million ()
Endologix, Inc. and TriVascular Technologies, Inc. Complete Merger ()
Text messaging interventions may improve medication adherence ()
Edwards Lifesciences’ TAVR sales increase 25 percent in fourth quarter ()
Pediatric hospital stops conducting elective heart surgeries pending internal review ()
Abbott acquires Kalila Medical, expands heart rhythm disorder portfolio ()
Trial results show mortality rates following TAVR decreased over time ()
Medtronic acquires privately held company to expand renal care business ()
University Medical Center New Orleans Implements Stereotaxis Platform for Advanced Treatment of Cardiac Arrhythmias ()
Seven researchers receive nearly $800,000 to examine congenital heart defect ()
Most U.S. adults do not know exercise guidelines for preventing heart disease ()
Sales of MitraClip device increase in Q4 ()